Background. Intravenous tPA (tissue plasminogen activator) therapy remains underutilized in patients with Acute Ischemic Stroke (AIS). Anecdotal data indicates that physicians are increasingly liable for administering and for failure to administer tPA. https://www.countryscenesaddleryandpetsuppliers.shop/product-category/hay-net-filler/